---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-055141"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2024-05-01T23:59:59+00:00"
generated_at: "2026-06-03T02:56:08.226548+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics moves headquarters to Iselin, NJ effective May 1, 2024

## Summary
- New headquarters address: 111 S. Wood Avenue, Unit #100, Iselin, NJ 08830.
- Company telephone number remains unchanged at (609) 619-3990.
- Effective date of the headquarters move is May 1, 2024.

## SEC filing metadata
- accession: 0001104659-24-055141
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2024-05-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465924055141/0001104659-24-055141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465924055141/tm2412887d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-055141
- JSON: https://secwatch.observer/filing/0001104659-24-055141.json
- Plain text: https://secwatch.observer/filing/0001104659-24-055141.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.